Literature DB >> 28118064

Co-expression network analysis of long noncoding RNAs (IncRNAs) and cancer genes revealsSFTA1P and CASC2abnormalities in lung squamous cell carcinoma.

Guang-Qing Huang1, Zun-Ping Ke2, Hai-Bo Hu3, Biao Gu4.   

Abstract

Lung squamous cell carcinoma(LSCC) is the most common and aggressive lung tumor with poor clinical outcome. Previously studies showed that deregulation of long noncoding RNAs (lncRNAs) were involved in LSCC. We intended to figure out the role of lncRNAs in the regulation process of cancer-related genes and pathways they are involved. Data of 552 samples, including 501 cancer samples and 51 normal ones, were extracted from The Cancer Genome Atlas (TCGA). Differentially expressed lncRNAs (DEIs) were screened out (FDR<0.05, |logFC|>1) and then followed by GO ontology and KEGG annotation analysis. Oncogenes from COSMIC data set and Tumor suppressor genes (TSGs) from TSGene data set were collected and analyzed by gene Set Enrichment Analysis (GSEA) . The differentially expressed oncogenes and tumor supressor gene (TSGs) were obtained and co-expression analysis was conducted to generate co-expression lncRNA-gene pairs, which can be helpful in figuring out the role of lncRNA in the regulation of oncogenes and tumor suppressor genes. A total of 31 lncRNAs with low expression levels and 37 lncRNAs with high expression levels were screened out and most of them were enriched in pathways such as meiosis, male gamete generation, defensins. Of note, SFTA1P and CASC2 were found to be related with most of the oncogenes and TSGs by co-expression analysis. We suggested SFTA1P and CASC2 played important role in the regulation of both oncogene and TSGs during the carcinogenesis of LSCC and have the potential to be applied in future diagnosis, prognostic process and target therapy of LSCC.

Entities:  

Keywords:  Enrichment pathways; lncRNA; lung squamous cell carcinoma; prognostic marker

Mesh:

Substances:

Year:  2017        PMID: 28118064      PMCID: PMC5362987          DOI: 10.1080/15384047.2017.1281494

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  28 in total

Review 1.  Long noncoding RNAs: functional surprises from the RNA world.

Authors:  Jeremy E Wilusz; Hongjae Sunwoo; David L Spector
Journal:  Genes Dev       Date:  2009-07-01       Impact factor: 11.361

Review 2.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

5.  Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA.

Authors:  Wenqiang Yu; David Gius; Patrick Onyango; Kristi Muldoon-Jacobs; Judith Karp; Andrew P Feinberg; Hengmi Cui
Journal:  Nature       Date:  2008-01-10       Impact factor: 49.962

6.  Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.

Authors:  Nicholas J Wang; Zachary Sanborn; Kelly L Arnett; Laura J Bayston; Wilson Liao; Charlotte M Proby; Irene M Leigh; Eric A Collisson; Patricia B Gordon; Lakshmi Jakkula; Sally Pennypacker; Yong Zou; Mimansa Sharma; Jeffrey P North; Swapna S Vemula; Theodora M Mauro; Isaac M Neuhaus; Philip E Leboit; Joe S Hur; Kyunghee Park; Nam Huh; Pui-Yan Kwok; Sarah T Arron; Pierre P Massion; Allen E Bale; David Haussler; James E Cleaver; Joe W Gray; Paul T Spellman; Andrew P South; Jon C Aster; Stephen C Blacklow; Raymond J Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

7.  The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression.

Authors:  Thomas Derrien; Rory Johnson; Giovanni Bussotti; Andrea Tanzer; Sarah Djebali; Hagen Tilgner; Gregory Guernec; David Martin; Angelika Merkel; David G Knowles; Julien Lagarde; Lavanya Veeravalli; Xiaoan Ruan; Yijun Ruan; Timo Lassmann; Piero Carninci; James B Brown; Leonard Lipovich; Jose M Gonzalez; Mark Thomas; Carrie A Davis; Ramin Shiekhattar; Thomas R Gingeras; Tim J Hubbard; Cedric Notredame; Jennifer Harrow; Roderic Guigó
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

8.  LncRNA2Function: a comprehensive resource for functional investigation of human lncRNAs based on RNA-seq data.

Authors:  Qinghua Jiang; Rui Ma; Jixuan Wang; Xiaoliang Wu; Shuilin Jin; Jiajie Peng; Renjie Tan; Tianjiao Zhang; Yu Li; Yadong Wang
Journal:  BMC Genomics       Date:  2015-01-29       Impact factor: 3.969

9.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

10.  Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications.

Authors:  Weihong Zhao; Jiancheng Luo; Shunchang Jiao
Journal:  Sci Rep       Date:  2014-10-13       Impact factor: 4.379

View more
  15 in total

Review 1.  CASC2: An emerging tumour-suppressing long noncoding RNA in human cancers and melanoma.

Authors:  Xin Yu; Heyi Zheng; Gary Tse; Lin Zhang; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2018-08-09       Impact factor: 6.831

2.  Novel lncRNA SFTA1P Promotes Tumor Growth by Down-Regulating miR-4766-5p via PI3K/AKT/mTOR Signaling Pathway in Hepatocellular Carcinoma.

Authors:  Guohong Huang; Yimei Yang; Mengxin Lv; Tian Huang; Xiaoyan Zhan; Wei Kang; Jianghou Hou
Journal:  Onco Targets Ther       Date:  2020-09-30       Impact factor: 4.147

3.  Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder.

Authors:  Zhen Li; Kang-Er Wang; Xie-Lai Zhou; Jin Zhou; Chun-Hua Ye
Journal:  Med Sci Monit       Date:  2018-01-23

4.  SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma.

Authors:  Youwen Xiong; Xinyi Zhang; Zhuohui Lin; Aizhen Xiong; Shanshan Xie; Jia Liang; Weifang Zhang
Journal:  Oncol Lett       Date:  2019-08-14       Impact factor: 2.967

5.  Construction of a specific SVM classifier and identification of molecular markers for lung adenocarcinoma based on lncRNA-miRNA-mRNA network.

Authors:  Jingming Zhao; Wei Cheng; Xigang He; Yanli Liu; Ji Li; Jiaxing Sun; Jinfeng Li; Fangfang Wang; Yufang Gao
Journal:  Onco Targets Ther       Date:  2018-05-25       Impact factor: 4.147

6.  Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma.

Authors:  Jing Sui; Si-Yi Xu; Jiali Han; Song-Ru Yang; Cheng-Yun Li; Li-Hong Yin; Yue-Pu Pu; Ge-Yu Liang
Journal:  Oncotarget       Date:  2017-07-27

7.  Identification of Three lncRNAs as Potential Predictive Biomarkers of Lung Adenocarcinoma.

Authors:  Donghui Jin; Yuxuan Song; Yuan Chen; Peng Zhang
Journal:  Biomed Res Int       Date:  2020-02-19       Impact factor: 3.411

8.  A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.

Authors:  Ming Zhang; Libing Sun; Yi Ru; Shasha Zhang; Junjun Miao; Pengda Guo; Jinghuan Lv; Feng Guo; Biao Liu
Journal:  Int J Mol Med       Date:  2020-04-27       Impact factor: 4.101

9.  The lncRNA NORAD/miR-520a-3p Facilitates Malignancy in Non-Small Cell Lung Cancer via PI3k/Akt/mTOR Signaling Pathway.

Authors:  Yunyan Wan; Zhouhong Yao; Weijuan Chen; Dezhi Li
Journal:  Onco Targets Ther       Date:  2020-02-19       Impact factor: 4.147

10.  Identification of potential prognostic long non-coding RNA for predicting survival in intrahepatic cholangiocarcinoma.

Authors:  Zeyu Zhang; Zhiming Wang; Yun Huang
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.